Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of 30-Day Readmission Using Machine Learning

NCT04849312 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT04849312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04849312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of 30-Day Readmission Using Machine Learning
Lead sponsor
Brigham and Women's Hospital
Phase
Observational
Overall status
Completed
Start date
June 1, 2017
Completion date
November 30, 2019
Enrollment
372 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulants; increased, asthma, atrial fibrillation rapid, chronic kidney diseases, chronic obstructive pulmonary disease, gout flare, heart failure, hypertensive urgency, infection